Efficacy of spesolimab for the treatment of GPP flares across prespecified patient subgroups in the Effisayil 1 study. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 19];7(2):s121. Available from: https://skin.dermsquared.com/skin/article/view/2015